Medicine's Brian Rini describes his study of therapy drug for kidney cancer
MEDIA |
February 26, 2019 STORY BY:
EDITORIAL STAFF
CNN: Brian Rini, professor of medicine, discussed a new study that found a combination of the targeted therapy drug axitinib and immunotherapy benefited kidney cancer patients. Rini was first author on the study.
